We are live on ! Find out more
TD Asset Management

TD Asset Management Portfolio holdings

AUM $123B
1-Year Est. Return 34.51%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$72.1B
AUM Growth
+$1.8B
Cap. Flow
-$3.77B
Cap. Flow %
-5.22%
Top 10 Hldgs %
26.35%
Holding
1,433
New
113
Increased
705
Reduced
392
Closed
81

Sector Composition

Rank Sector Weight
1 Financials 19.06%
2 Technology 15.4%
3 Healthcare 9.1%
4 Industrials 8.83%
5 Communication Services 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYRG icon
1276
MYR Group
MYRG
$5.26B
$424K ﹤0.01%
+11,400
New +$404K
TARA icon
1277
Protara Therapeutics
TARA
$223M
$424K ﹤0.01%
+25,185
New +$584K
SENEA icon
1278
Seneca Foods Class A
SENEA
$1.15B
$422K ﹤0.01%
+11,800
New +$476K
UAA icon
1279
Under Armour
UAA
$2.89B
$422K ﹤0.01%
37,559
+3,650
+11% +$38.4K
SNBR
1280
DELISTED
Sleep Number
SNBR
$421K ﹤0.01%
+8,600
New +$404K
MOG.A icon
1281
Moog Inc Class A
MOG.A
$12.5B
$419K ﹤0.01%
6,600
ODT
1282
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$418K ﹤0.01%
31,090
EXK
1283
Endeavour Silver
EXK
$2.29B
$416K ﹤0.01%
+118,696
New +$439K
NEX
1284
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$416K ﹤0.01%
224,600
ALEC icon
1285
Alector
ALEC
$168M
$415K ﹤0.01%
39,357
EEMV icon
1286
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.47B
$414K ﹤0.01%
7,500
-32,500
-81% -$1.79M
APRE icon
1287
Aprea Therapeutics
APRE
$7.4M
$411K ﹤0.01%
854
ARYBU
1288
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
$409K ﹤0.01%
37,158
PE
1289
DELISTED
PARSLEY ENERGY INC
PE
$406K ﹤0.01%
43,406
HEI icon
1290
HEICO Corp
HEI
$50.4B
$405K ﹤0.01%
3,869
-42,304
-92% -$4.37M
IMVT icon
1291
Immunovant
IMVT
$7.91B
$394K ﹤0.01%
+11,183
New +$336K
NP
1292
DELISTED
Neenah, Inc. Common Stock
NP
$390K ﹤0.01%
10,400
UA icon
1293
Under Armour Class C
UA
$2.83B
$385K ﹤0.01%
39,164
+4,860
+14% +$45.6K
IOSP icon
1294
Innospec
IOSP
$2.11B
$380K ﹤0.01%
6,000
-600
-9% -$44.6K
HCI icon
1295
HCI Group
HCI
$2.29B
$375K ﹤0.01%
+7,600
New +$386K
MTRN icon
1296
Materion
MTRN
$4.45B
$375K ﹤0.01%
7,200
-13,600
-65% -$769K
PSTH.WS
1297
DELISTED
Pershing Square Tontine Holdings, Ltd. Warrants, exercisable for one share of Class A Common Stock f
PSTH.WS
$370K ﹤0.01%
+51,550
New +$372K
NAK
1298
Northern Dynasty Minerals
NAK
$818M
$364K ﹤0.01%
+374,349
New +$514K
ACBI
1299
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$361K ﹤0.01%
31,789
HAIN icon
1300
Hain Celestial
HAIN
$45.5M
$356K ﹤0.01%
10,392
-534
-5% -$17.7K

Similar funds

TD Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, TD Asset Management held 1,433 positions worth $72.1B, up 2.6% from $70.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TD Asset Management withdrew a net $3.77B in Q3 2020, closing 81 positions and reducing 392 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $44.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.

Against the trend, TD Asset Management opened a new position in State Street Consumer Staples Select Sector SPDR ETF worth $38.9M.

  • TD Asset Management's largest Q3 2020 buy was State Street Consumer Staples Select Sector SPDR ETF: 607,194 shares worth $38.9M.
  • TD Asset Management added most to Xtrackers Harvest CSI 300 China A-Shares ETF in Q3 2020, an estimated $105M increase.
  • TD Asset Management's biggest Q3 2020 reduction was Royal Bank of Canada, cutting an estimated $490M.
  • TD Asset Management fully exited Seagen Inc. Common Stock in Q3 2020, selling an estimated $44.9M.
  • TD Asset Management's ten largest holdings make up 26% of its $72.1B portfolio in Q3 2020.
  • TD Asset Management opened 113 new positions and closed 81 in Q3 2020.
  • TD Asset Management's portfolio value rose 2.6% quarter-over-quarter to $72.1B.

Based on TD Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.